Johnson & Johnson (JNJ) Seeks Court Aid to Protect Its Glucose Monitoring Test
9/12/2013 7:55:54 AM
With more than 250 units making and marketing therapeutic products worldwide, Johnson & Johnson JNJ -0.03% (JNJ) is one of the most diversified global healthcare companies. And as a leader in pharmaceuticals, medical devices, and consumer personal-care products, the company not surprisingly makes sure it adequately protects its turf. Of late, its largest division, the medical device and diagnostic operations that generates some 40% of the company’s total sales, has been a focus of some of its attention.
Help employers find you! Check out all the jobs and post your resume.
comments powered by